BioNTech and Genmab Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy Candidates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ACN
3. NVDA
4. GOOGL
5. MU
6. DFTX
7. USO
8. APGE
9. ABBV
10. NAVN

Go back to BioNTech and Genmab Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy Candidates
(NASDAQ: BNTX) Delayed: 90.19 --0 (-0%)
Previous Close $90.19    52 Week High $ 
Open $90.19    52 Week Low $ 
Day High $90.19    P/E N/A 
Day Low $90.19    EPS $ 
Volume 1,828